Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Frumovitz

Showing results (141-150 of 224) with videos related to

Pageof 23
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancerTeresa L Pan, Rene Pareja, Luis Chiva, et al.
Gynecologic Oncology|December 24, 2013
A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinomaJanelle Pakish, Pamela T Soliman, Michael Frumovitz, et al.
JAMA Oncology|June 12, 2020
Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysisRoni Nitecki, Pedro T Ramirez, Michael Frumovitz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2020
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiationShannon D Armbruster, Bryan M Fellman, Anuja Jhingran, et al.
American Journal of Obstetrics and Gynecology|December 14, 2022
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) studyMichael Frumovitz, Gary B Chisholm, Anuja Jhingran, et al.
Gynecologic Oncology|September 28, 2010
Rate of vaginal cuff separation following laparoscopic or robotic hysterectomyAlpa M Nick, Jimena Lange, Michael Frumovitz, et al.
Clinical Nuclear Medicine|February 9, 2010
Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphyKatsuhiro Kobayashi, Pedro T Ramirez, Edmund E Kim, et al.
Frontiers in Immunology|October 5, 2018
Gene Expression Analysis Identifies Novel Targets for Cervical Cancer TherapyJason Roszik, Kari L Ring, Khalida M Wani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2024
Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancerTeresa L Pan, Rene Pareja, Luis Chiva, et al.
Gynecologic Oncology|March 14, 2013
Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignanciesAnze Urh, Pamela T Soliman, Kathleen M Schmeler, et al.
Pageof 23

Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancerTeresa L Pan, Rene Pareja, Luis Chiva, et al.
Gynecologic Oncology|December 24, 2013
A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinomaJanelle Pakish, Pamela T Soliman, Michael Frumovitz, et al.
JAMA Oncology|June 12, 2020
Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysisRoni Nitecki, Pedro T Ramirez, Michael Frumovitz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2020
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiationShannon D Armbruster, Bryan M Fellman, Anuja Jhingran, et al.
American Journal of Obstetrics and Gynecology|December 14, 2022
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) studyMichael Frumovitz, Gary B Chisholm, Anuja Jhingran, et al.
Gynecologic Oncology|September 28, 2010
Rate of vaginal cuff separation following laparoscopic or robotic hysterectomyAlpa M Nick, Jimena Lange, Michael Frumovitz, et al.
Clinical Nuclear Medicine|February 9, 2010
Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphyKatsuhiro Kobayashi, Pedro T Ramirez, Edmund E Kim, et al.
Frontiers in Immunology|October 5, 2018
Gene Expression Analysis Identifies Novel Targets for Cervical Cancer TherapyJason Roszik, Kari L Ring, Khalida M Wani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2024
Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancerTeresa L Pan, Rene Pareja, Luis Chiva, et al.
Gynecologic Oncology|March 14, 2013
Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignanciesAnze Urh, Pamela T Soliman, Kathleen M Schmeler, et al.
Pageof 23